Applied Industrial Technologies Reports Fiscal 2023 Second Quarter Results
Applied Industrial Technologies reported net sales of $1.1 billion for fiscal Q2 2023, up 20.9% year-over-year, achieving an organic growth of 21.1%. The company recorded net income of $80.5 million, translating to an EPS of $2.05, reflecting a 40.8% increase YoY. EBITDA rose to $125.5 million, indicating a 35.6% growth. The quarterly dividend increased to $0.35 per share. The company raised its fiscal 2023 guidance, projecting EPS between $8.10 and $8.50, and sales growth of 13% to 15%.
- Net sales increased by 20.9% YoY to $1.1 billion.
- Net income rose to $80.5 million, EPS of $2.05, up 40.8% YoY.
- EBITDA reached $125.5 million, reflecting a 35.6% increase.
- Quarterly dividend increased to $0.35 per share.
- Raised fiscal 2023 guidance: EPS projected at $8.10 to $8.50; sales growth of 13% to 15%.
- Organic sales growth of low-twenty percent month-to-date in January.
- Negative impact from foreign currency translation of 0.7%.
- Ongoing economic uncertainty and inflationary pressures highlighted.
-
Net Sales of Up$1.1 Billion 20.9% YoY; Up21.1% on an Organic Basis -
Net Income of
; EPS of$80.5 Million Up$2.05 40.8% YoY -
EBITDA of
Up$125.5 Million 35.6% YoY -
Quarterly Dividend Increased to
Per Share$0.35 - Raising Fiscal 2023 Guidance
Net sales for the quarter increased
Updated Fiscal 2023 Guidance
For fiscal 2023, the Company now projects EPS of
Dividend
Today the Company also announced that its Board of Directors approved an increase in the quarterly cash dividend to
Conference Call Information
Applied will host its quarterly conference call for investors and analysts at
About Applied®
This press release contains statements that are forward-looking, as that term is defined by the
CONDENSED STATEMENTS OF CONSOLIDATED INCOME | |||||||||||
(Unaudited) | |||||||||||
(In thousands, except per share data) | |||||||||||
Three Months Ended
|
|
Six Months Ended
|
|||||||||
|
2022 |
|
2021 |
|
|
|
2022 |
|
2021 |
|
|
$ |
1,060,280 |
$ |
876,874 |
|
$ |
2,122,685 |
$ |
1,768,555 |
|
||
Cost of sales |
|
751,775 |
|
619,249 |
|
|
1,507,397 |
|
1,255,590 |
|
|
Gross Profit |
|
308,505 |
|
257,625 |
|
|
615,288 |
|
512,965 |
|
|
Selling, distribution and administrative expense, | |||||||||||
including depreciation |
|
195,612 |
|
179,448 |
|
|
395,863 |
|
360,174 |
|
|
Operating Income |
|
112,893 |
|
78,177 |
|
|
219,425 |
|
152,791 |
|
|
Interest expense, net |
|
6,185 |
|
7,007 |
|
|
12,665 |
|
14,397 |
|
|
Other expense (income), net |
|
758 |
|
(869 |
) |
|
1,766 |
|
(1,181 |
) |
|
Income Before Income Taxes |
|
105,950 |
|
72,039 |
|
|
204,994 |
|
139,575 |
|
|
Income tax expense |
|
25,493 |
|
15,013 |
|
|
47,657 |
|
29,580 |
|
|
Net Income | $ |
80,457 |
$ |
57,026 |
|
$ |
157,337 |
$ |
109,995 |
|
|
Net Income Per Share - Basic | $ |
2.09 |
$ |
1.48 |
|
$ |
4.08 |
$ |
2.86 |
|
|
Net Income Per Share - Diluted | $ |
2.05 |
$ |
1.46 |
|
$ |
4.02 |
$ |
2.81 |
|
|
Average Shares Outstanding - Basic |
|
38,579 |
|
38,456 |
|
|
38,552 |
|
38,479 |
|
|
Average Shares Outstanding - Diluted |
|
39,208 |
|
39,122 |
|
|
39,162 |
|
39,104 |
|
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS | |||||
1) Applied uses the last-in, first-out (LIFO) method of valuing |
CONDENSED CONSOLIDATED BALANCE SHEETS | |||||
(Unaudited) | |||||
(In thousands) | |||||
2022 |
2022 |
||||
Assets | |||||
Cash and cash equivalents | $ |
165,538 |
$ |
184,474 |
|
Accounts receivable, net |
|
654,510 |
|
656,429 |
|
Inventories |
|
523,021 |
|
449,821 |
|
Other current assets |
|
79,183 |
|
68,805 |
|
Total current assets |
|
1,422,252 |
|
1,359,529 |
|
Property, net |
|
112,790 |
|
111,896 |
|
Operating lease assets, net |
|
105,797 |
|
108,052 |
|
Intangibles, net |
|
246,739 |
|
250,590 |
|
|
572,319 |
|
563,205 |
||
Other assets |
|
63,007 |
|
59,316 |
|
Total Assets | $ |
2,522,904 |
$ |
2,452,588 |
|
Liabilities | |||||
Accounts payable | $ |
250,407 |
$ |
259,463 |
|
Current portion of long-term debt |
|
25,189 |
|
40,174 |
|
Other accrued liabilities |
|
171,609 |
|
199,990 |
|
Total current liabilities |
|
447,205 |
|
499,627 |
|
Long-term debt |
|
624,052 |
|
649,150 |
|
Other liabilities |
|
155,771 |
|
154,456 |
|
Total Liabilities |
|
1,227,028 |
|
1,303,233 |
|
Shareholders' Equity |
|
1,295,876 |
|
1,149,355 |
|
Total Liabilities and Shareholders' Equity | $ |
2,522,904 |
$ |
2,452,588 |
CONDENSED STATEMENTS OF CONSOLIDATED CASH FLOWS | |||||||
(Unaudited) | |||||||
(In thousands) | |||||||
Six Months Ended |
|||||||
|
2022 |
|
|
2021 |
|
||
Cash Flows from Operating Activities | |||||||
Net income | $ |
157,337 |
|
$ |
109,995 |
|
|
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
Depreciation and amortization of property |
|
11,033 |
|
|
10,863 |
|
|
Amortization of intangibles |
|
15,519 |
|
|
16,205 |
|
|
Provision for losses on accounts receivable |
|
9,573 |
|
|
1,328 |
|
|
Amortization of stock appreciation rights and options |
|
1,871 |
|
|
2,516 |
|
|
Other share-based compensation expense |
|
4,001 |
|
|
3,268 |
|
|
Changes in assets and liabilities, net of acquisitions |
|
(111,542 |
) |
|
(61,066 |
) |
|
Other, net |
|
1,031 |
|
|
(1,845 |
) |
|
|
88,823 |
|
|
81,264 |
|
||
Cash Flows from Investing Activities | |||||||
Acquisition of businesses, net of cash acquired |
|
(25,516 |
) |
|
(6,974 |
) |
|
Capital expenditures |
|
(12,817 |
) |
|
(7,510 |
) |
|
Proceeds from property sales |
|
128 |
|
|
442 |
|
|
Cash payments for loans on company-owned life insurance |
|
- |
|
|
(14,835 |
) |
|
|
(38,205 |
) |
|
(28,877 |
) |
||
Cash Flows from Financing Activities | |||||||
Net borrowings under revolving credit facility |
|
- |
|
|
442,592 |
|
|
Long-term debt repayments |
|
(40,123 |
) |
|
(550,371 |
) |
|
Interest rate swap settlement receipts (payments) |
|
2,684 |
|
|
(3,294 |
) |
|
Payment of debt issuance costs |
|
- |
|
|
(1,794 |
) |
|
Purchases of treasury shares |
|
(716 |
) |
|
(10,064 |
) |
|
Dividends paid |
|
(26,259 |
) |
|
(25,465 |
) |
|
Acquisition holdback payments |
|
(1,510 |
) |
|
(1,070 |
) |
|
Taxes paid for shares withheld for equity awards |
|
(3,340 |
) |
|
(4,093 |
) |
|
Exercise of stock appreciation rights and options |
|
127 |
|
|
116 |
|
|
|
(69,137 |
) |
|
(153,443 |
) |
||
Effect of Exchange Rate Changes on Cash |
|
(417 |
) |
|
(1,846 |
) |
|
Decrease in cash and cash equivalents |
|
(18,936 |
) |
|
(102,902 |
) |
|
Cash and Cash Equivalents at Beginning of Period |
|
184,474 |
|
|
257,745 |
|
|
Cash and Cash Equivalents at End of Period | $ |
165,538 |
|
$ |
154,843 |
|
|
|
||||||
SUPPLEMENTAL INFORMATION |
||||||
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES |
||||||
(Unaudited) |
||||||
(In thousands) |
||||||
The Company supplemented the reporting of financial information determined under |
Reconciliation of Net Income, a GAAP financial measure, to EBITDA, a non-GAAP financial measure: | |||||||||
Three Months Ended
|
|
Six Months Ended
|
|||||||
|
2022 |
|
2021 |
|
|
2022 |
|
2021 |
|
Net Income | $ |
80,457 |
$ |
57,026 |
$ |
157,337 |
$ |
109,995 |
|
Interest expense, net |
|
6,185 |
|
7,007 |
|
12,665 |
|
14,397 |
|
Income tax expense |
|
25,493 |
|
15,013 |
|
47,657 |
|
29,580 |
|
Depreciation and amortization of property |
|
5,552 |
|
5,436 |
|
11,033 |
|
10,863 |
|
Amortization of intangibles |
|
7,814 |
|
8,084 |
|
15,519 |
|
16,205 |
|
EBITDA | $ |
125,501 |
$ |
92,566 |
$ |
244,211 |
$ |
181,040 |
|
The Company defines EBITDA as Earnings from operations before Interest, Taxes, Depreciation, and Amortization, a non-GAAP financial measure. Adjusted EBITDA excludes items that may not be indicative of core operating results, a non-GAAP financial measure. |
Reconciliation of |
|||||||||||||
Three Months Ended
|
|
Six Months Ended
|
|||||||||||
|
2022 |
|
|
2021 |
|
|
|
2022 |
|
|
2021 |
|
|
$ |
62,880 |
|
$ |
32,622 |
|
$ |
88,823 |
|
$ |
81,264 |
|
||
Capital expenditures |
|
(7,263 |
) |
|
(3,889 |
) |
|
(12,817 |
) |
|
(7,510 |
) |
|
Free Cash Flow | $ |
55,617 |
|
$ |
28,733 |
|
$ |
76,006 |
|
$ |
73,754 |
|
|
Free cash flow is defined as net cash provided by operating activities less capital expenditures, a non-GAAP financial measure. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230126005153/en/
Director – Investor Relations &
216-426-4887 / rcieslak@applied.com
Source:
FAQ
What were the net sales for AIT in Q2 2023?
What is the EPS for AIT in fiscal 2023?
What is the new dividend amount for AIT?
How did AIT perform in terms of EBITDA in Q2 2023?